Free Submission Public Relations &
Deutsch English


Algeta ASA : Annual General Meeting held in Algeta ASA

Print article Print article
Copyright © Thomson Reuters 2013. All rights reserved.
2013-04-11 18:26:55 -

Oslo, Norway, 11 April 2013 - Algeta ASA (OSE: ALGETA) announces that its Annual
General Meeting (AGM) was held today, and all items in the notice for the AGM
were resolved in accordance with the proposals from the Board of Directors.


For further information, please contact:

 Mike Booth / Renate Birkeli            +47 23 00 67 32

 Communications & Corporate Affairs

 Media enquiries:

 Mark Swallow 
+44 207 638 9571 Citigate Dewe Rogerson Knut Ekern +47 22 04 82 00 Gambit Hill & Knowlton Kari Watson +1 781 235 3060 MacDougall Biomedical Communications Investor enquiries: Tricia Swanson +1 646 378 2953 The Trout Group About Algeta Algeta is a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Algeta ASA via Thomson Reuters ONE [HUG#1692513]

Press Information:

Contact Person:

Disclaimer: © 2014 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact